Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phio Pharmaceuticals (PHIO) Equity Ratio (2016 - 2021)

Historic Equity Ratio for Phio Pharmaceuticals (PHIO) over the last 10 years, with Q3 2021 value amounting to 0.9.

  • Phio Pharmaceuticals' Equity Ratio rose 663.7% to 0.9 in Q3 2021 from the same period last year, while for Sep 2021 it was 0.9, marking a year-over-year increase of 663.7%. This contributed to the annual value of 0.83 for FY2020, which is 1566.95% up from last year.
  • Phio Pharmaceuticals' Equity Ratio amounted to 0.9 in Q3 2021, which was up 663.7% from 0.91 recorded in Q2 2021.
  • Phio Pharmaceuticals' Equity Ratio's 5-year high stood at 0.93 during Q1 2021, with a 5-year trough of 0.18 in Q1 2018.
  • In the last 5 years, Phio Pharmaceuticals' Equity Ratio had a median value of 0.8 in 2019 and averaged 0.73.
  • As far as peak fluctuations go, Phio Pharmaceuticals' Equity Ratio tumbled by 7661.09% in 2018, and later skyrocketed by 36464.99% in 2019.
  • Over the past 5 years, Phio Pharmaceuticals' Equity Ratio (Quarter) stood at 0.45 in 2017, then skyrocketed by 98.12% to 0.89 in 2018, then fell by 19.31% to 0.72 in 2019, then grew by 15.67% to 0.83 in 2020, then grew by 9.24% to 0.9 in 2021.
  • Its Equity Ratio stands at 0.9 for Q3 2021, versus 0.91 for Q2 2021 and 0.93 for Q1 2021.